Use of the Glucagon-Like Peptide-2 Analog, glepaglutide, in the Treatment of Patients with Short Bowel Syndrome

Rahim Mohammad Naimi

    OriginalsprogEngelsk
    ForlagFaculty of Health Sciences, University of Copenhagen
    StatusUdgivet - 2019

    Citationsformater